MyJournals Home  

RSS FeedsImpact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials (Journal of Translational Medicine)

 
 

4 august 2020 01:22:06

 
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials (Journal of Translational Medicine)
 


We sought to identify patient subgroups with distinct postprogression overall survival (ppOS) outcomes and investigate the impact of original treatment assignment and initial postprogression treatment (ppRx) o...


 
73 viewsCategory: Medicine
 
Identifying the pattern of immune related cells and genes in the peripheral blood of ischemic stroke (Journal of Translational Medicine)
An examination of trends in antibiotic prescribing in primary care and the association with area-level deprivation in England (BMC Public Health)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten